用低,低蛋白和低脂肪米饭饮食治疗恶性高血压
Scott L Sanoff1, Philip J Klemmer2, Francis A Neelon3
1Division of Nephrology, Department of Medicine (S.L.S., D.L., A.B., W.M., P.-H.L.), Duke University School of Medicine, Durham, NC.
Hypertension (Dallas, Tex. : 1979)
|October 27, 2025
概括
在4周内,大米饮食 (RD) 显著降低了恶性高血压患者的血压. 饮食坚持,以尿液中化物水平为指标,与更大的血压降低相关.
科学领域:
- 心血管医学 心血管医学
- 营养科学 营养科学
- 高血压研究 高血压研究
背景情况:
- 米饭饮食 (RD) 是一种非常低,低蛋白和低脂肪的饮食,在有效药物出现之前,从历史上开始用于治疗恶性高血压.
- 恶性高血压是一种严重的高血压形式,其特点是显著的血压升高和目标器官损伤.
研究的目的:
- 追溯分析大米饮食降低患有恶性高血压的患者血压的有效性.
- 为了确定与此患者队列中血压降低相关的因素,例如饮食坚持.
主要方法:
- 544名恶性高血压患者从17487个大米饮食表进行了回顾性分析.
- 排除标准包括糖尿病,脑瘤或之前的同情切除术.
- 血压变化和饮食坚持 (通过尿液化物评估) 在4周内进行了评估.
主要成果:
- 基线血压的中位数为213/128毫米柱;到第4周,血压显著下降至179/108毫米柱.
- 尿液中化物水平大幅下降,表明遵守饮食.
- 尿液中化物含量较低,血压较高,以及女性性别与更大的静脉血压降低有关.
结论:
- 米饭饮食是一种有效的干预措施,可以在患有恶性高血压的患者中快速降低血压.
- 通过尿液化物测量饮食的坚持,在饮食的有效性中起着至关重要的作用.
- 米饭饮食的降血压效果与同时服用的抗高血压药物独立观察到.
相关概念视频
Hypertension IV: Drug Therapy and Lifestyle Modifications
618
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
618
Hypertension V: Nursing Management
355
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
355
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
928
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
928
Antihypertensive Drugs: Potassium-Sparing Diuretics
2.2K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.2K
Nephrotic Syndrome III : Nursing Management
278
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
278
Nephrotic Syndrome II : Assessment and Medical Management
197
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
197


